Clinical trials
Completed Infertility trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,018 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 9 |
| 2002 | 10 |
| 2003 | 18 |
| 2004 | 18 |
| 2005 | 23 |
| 2006 | 28 |
| 2007 | 26 |
| 2008 | 44 |
| 2009 | 54 |
| 2010 | 48 |
| 2011 | 48 |
| 2012 | 59 |
| 2013 | 62 |
| 2014 | 80 |
| 2015 | 56 |
| 2016 | 51 |
| 2017 | 45 |
| 2018 | 71 |
| 2019 | 45 |
| 2020 | 48 |
| 2021 | 34 |
| 2022 | 43 |
| 2023 | 28 |
| 2024 | 28 |
| 2025 | 15 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,018 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ferring Pharmaceuticals | 33 |
| Cairo University | 29 |
| Merck KGaA, Darmstadt, Germany | 25 |
| Universitair Ziekenhuis Brussel | 22 |
| Ibn Sina Hospital | 17 |
| Reproductive Medicine Associates of New Jersey | 17 |
| Royan Institute | 17 |
| Clinique Ovo | 13 |
| Instituto Valenciano de Infertilidad, IVI VALENCIA | 13 |
| Fundacion Dexeus | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility | 1,018 |
| Infertility, Female | 54 |
| Polycystic Ovary Syndrome | 51 |
| Endometriosis | 24 |
| Infertility, Male | 20 |
| Anovulation | 19 |
| Abortion, Spontaneous | 16 |
| Obesity | 14 |
| Pain | 14 |
| Anxiety Disorders | 11 |
Trials
Showing 26 to 50 of 1,018. Each trial links to its page on Pharma Observatory.
918 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.